Advanced search×

Predictive biomarkers for the activity of mammalian target of rapamycin (mTOR) inhibitors.

Catherine Delbaldo, Sébastien Albert, Chantal Dreyer, Marie-Paule Sablin, Maria Serova, Eric Raymond, and Sandrine Faivre

Target Oncol 6(2):119-24 (2011) PMID 21533544

In the quest for personalized medicine, only a few biological parameters are routinely used to select patients prior to the initiation of anticancer targeted therapies, including mTOR inhibitors. Identifying biological factors that may predict efficacy or resistance to mTOR inhibitors represents an important challenge since rapalogs may exert antitumor effects through multiple mechanisms of action. Despite the fact that no such a factor is currently available, several molecular patterns are emerging, correlating with sensitivity and/or resistance to rapalogs. While activation of the phosphatidylinositol 3 kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway, overexpression of cyclin D1, and functional apoptosis seem to sensitize tumor cells to rapalogs, Bcl2 overexpression or KRAS mutations are reported to be associated with resistance to mTOR inhibitors in several preclinical models. Translational research aimed at validating those parameters in clinical trials is ongoing.

DOI: 10.1007/s11523-011-0177-6
Version: za2963e q8za0 q8zb3 q8zca q8zd3 q8ze8 q8zfc q8zgd

Similar articles you may find interesting…

  1. Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil.
    Célia B G CB Antoneli, Karina C B KC Ribeiro, ... Marcio M Malogolowkin

    J Pediatr Hematol Oncol 28(6):342-5 (2006) PMID 16794500

    To evaluate the efficacy of conservative management of intraocular retinoblastoma with chemoreduction combined with local therapy with or without plaque radiation in the preservation of the eye, and avoidance of external beam radiation therapy (EBRT) (success rate). From 1995 to 2000, 84 newly diagno...
  2. The emerging mechanisms of isoform-specific PI3K signalling.
    Bart B Vanhaesebroeck, Julie J Guillermet-Guibert, ... Benoit B Bilanges

    Audio, Transactions of the IRE Profession... 11(5):329-41 (2010) PMID 20379207

    Phosphoinositide 3-kinases (PI3Ks) function early in intracellular signal transduction pathways and affect many biological functions. A further level of complexity derives from the existence of eight PI3K isoforms, which are divided into class I, class II and class III PI3Ks. PI3K signalling has been...
  3. Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer model.
    K K Tabata, S S Kurosaka, ... T C TC Thompson

    Gene Ther 18(10):969-78 (2011) PMID 21512508

    We previously identified the mouse and human Glipr1 and GLIPR1/RTVP-1 genes, respectively, as direct p53 targets with proapoptotic activities in various cancer cell lines, including prostate cancer (PCa). Intratumoral injection of an adenoviral vector capable of efficient transduction and expression...